Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16099598rdf:typepubmed:Citationlld:pubmed
pubmed-article:16099598lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16099598lifeskim:mentionsumls-concept:C0476089lld:lifeskim
pubmed-article:16099598lifeskim:mentionsumls-concept:C0006098lld:lifeskim
pubmed-article:16099598lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:16099598lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:16099598lifeskim:mentionsumls-concept:C0205187lld:lifeskim
pubmed-article:16099598lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:16099598lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:16099598pubmed:issue4lld:pubmed
pubmed-article:16099598pubmed:dateCreated2005-10-28lld:pubmed
pubmed-article:16099598pubmed:abstractTextTotal-abdominal hysterectomy and bilateral salpingo-oophorectomy (TAHBSO) is the gold-standard therapy for patients with endometrial carcinoma. However, patients with high operative risks are usually treated with radiation therapy (RT) alone. The goal of this study was to update our experience of high-dose-rate brachytherapy (HDRB), with or without external-beam irradiation (EBRT), for such patients.lld:pubmed
pubmed-article:16099598pubmed:languageenglld:pubmed
pubmed-article:16099598pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16099598pubmed:citationSubsetIMlld:pubmed
pubmed-article:16099598pubmed:statusMEDLINElld:pubmed
pubmed-article:16099598pubmed:monthNovlld:pubmed
pubmed-article:16099598pubmed:issn0360-3016lld:pubmed
pubmed-article:16099598pubmed:authorpubmed-author:SouhamiLuisLlld:pubmed
pubmed-article:16099598pubmed:authorpubmed-author:GilbertLucyLlld:pubmed
pubmed-article:16099598pubmed:authorpubmed-author:PortelanceLor...lld:pubmed
pubmed-article:16099598pubmed:authorpubmed-author:NiaziTamim...lld:pubmed
pubmed-article:16099598pubmed:authorpubmed-author:BahoricBorisBlld:pubmed
pubmed-article:16099598pubmed:authorpubmed-author:StanimirGeral...lld:pubmed
pubmed-article:16099598pubmed:issnTypePrintlld:pubmed
pubmed-article:16099598pubmed:day15lld:pubmed
pubmed-article:16099598pubmed:volume63lld:pubmed
pubmed-article:16099598pubmed:ownerNLMlld:pubmed
pubmed-article:16099598pubmed:authorsCompleteYlld:pubmed
pubmed-article:16099598pubmed:pagination1108-13lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:meshHeadingpubmed-meshheading:16099598...lld:pubmed
pubmed-article:16099598pubmed:year2005lld:pubmed
pubmed-article:16099598pubmed:articleTitleLong-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma.lld:pubmed
pubmed-article:16099598pubmed:affiliationDepartment of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada.lld:pubmed
pubmed-article:16099598pubmed:publicationTypeJournal Articlelld:pubmed